Literature DB >> 1674780

Humanised monoclonal antibody to respiratory syncytial virus.

G Taylor, J Furze, P R Tempest, P Bremner, F J Carr, W J Harris.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1674780     DOI： 10.1016/0140-6736(91)93091-m

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  8 in total

1.  Synergistic protection of mice against plague with monoclonal antibodies specific for the F1 and V antigens of Yersinia pestis.

Authors:  Jim Hill; Catherine Copse; Sophie Leary; Anthony J Stagg; E Diane Williamson; Richard W Titball
Journal:  Infect Immun       Date:  2003-04       Impact factor: 3.441

Review 2.  Demystified...recombinant antibodies.

Authors:  K A Smith; P N Nelson; P Warren; S J Astley; P G Murray; J Greenman
Journal:  J Clin Pathol       Date:  2004-09       Impact factor: 3.411

Review 3.  Respiratory syncytial virus infection: immune response, immunopathogenesis, and treatment.

Authors:  J B Domachowske; H F Rosenberg
Journal:  Clin Microbiol Rev       Date:  1999-04       Impact factor: 26.132

4.  Human antibody responses to mature and immature forms of viral envelope in respiratory syncytial virus infection: significance for subunit vaccines.

Authors:  H Sakurai; R A Williamson; J E Crowe; J A Beeler; P Poignard; R B Bastidas; R M Chanock; D R Burton
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

5.  Prophylactic administration of a complementarity-determining region derived from a neutralizing monoclonal antibody is effective against respiratory syncytial virus infection in BALB/c mice.

Authors:  C Bourgeois; J B Bour; L S Aho; P Pothier
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

Review 6.  Hyperimmune globulins in prevention and treatment of respiratory syncytial virus infections.

Authors:  V G Hemming; G A Prince; J R Groothuis; G R Siber
Journal:  Clin Microbiol Rev       Date:  1995-01       Impact factor: 26.132

7.  Recent advances in the study of human antibody responses to influenza virus using optimized human hybridoma approaches.

Authors:  James E Crowe
Journal:  Vaccine       Date:  2009-12-30       Impact factor: 3.641

Review 8.  Respiratory syncytial virus.

Authors:  O Ruuskanen; P L Ogra
Journal:  Curr Probl Pediatr       Date:  1993-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.